References
- Aboulghar A. M., Mansour R. T., Serour G. I., Anun Y., Abbas A. M., Salah I. M. Ovarian super-stimulation and intrauterine insemination for the treatment of unexplained infertility. Fertil. Steril 1993; 60: 303–6
- Corsan G. H., Kemmann E. The role of superovulation with menotropins in ovulatory infertility. h'ertil. Steril. 1991; 55: 468–77
- Masearenhas L., Khastgir G., Davies W. A. R., Lee S. Superovulation and timed intercourses; can it provide a reasonable alternative for those unable to afford assisted conception?. Hum. 1994; 9: 67–70
- Chang A. P., Rafael R. W., Forte C. C. Influence of weight in the induction of ovulation with human menopausal gonadotropin and human chorionic gonadotropin. Fertil. Steril. 1986; 46: 599–602
- McClure N., McQuinn B., McDonald J., Kovr-s G. T., Healy D. L., Burger H. G. Body weight, body mass index and age: predictors of menotropin dose and cycle outcome in polycystic ovarian syndrome. fertil. Steril 1992; 58: 622–4
- Shepard M. K., Balmaceda J. P., Leija C. G. Relationship of weight to successful induction of ovulation with clomiphene citrate. Fertil. Steril. 1979; 32: 641–4
- Zaadstra B. M., Seidell J. C., Van Noord P. A., Velde E. R., Habbema J. D., Vrieswijk B., Karbaat J. Fat and female fecundity: prospective study of effect of body fat distribution on conception rates. Br. Med. J. 1993; 306: 484–7
- Halme J., Hammond M. G., Talbert L. M., O'Rand M., Bailey L., Sloan C. Positive correlation between body weight, length of human menopausal gonadotropin stimulation, and oocyte fertilization rate. Fertil. Steril. 1986; 45: 372–6
- Halme J., Hammond M. G., Bailey L., Talbert L. M. Lower doses of human menopausal gonadotropin are associated with improved success within vitro fertilization in women with low body weight. Am J. Obstet. Gynecol 1988; 158: 64–8
- Lewis C. G., Warnes G. M., Wang X., Matthews C. D. Failure of body mass index or body weight to influence markedly the response to ovarian hyperstimulation in normal cycling women. Fertil. Steril. 1990; 53: 1097–9
- McClamrock H. D., Bass K. M., Adashi E. Y. Ovarian hyperandrogenism: the role of and sensitivity to gonadotropins. Fertil. Steril. 1991; 55: 73–9
- Nestler J. E., Barlascini C O., Matt D. W., Steingold K. A., Plymate S. R., Clore J. N. Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 1989; 68: 1027–30
- Pasquali R., Casimirri F., Plate L. Characterization of obese women with reduced sex-hormone-binding globulin concentrations. Horm. Metab. Res. 1990; 22: 303–6
- Adams J., Poison D. W., Franks S. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br. Med. J. 1986; 293: 355–9
- Franks S. Polycystic ovary syndrome: a change in perspective. Clin. Endocrinol 1989; 31: 87–120
- Sher G., Knutzen V. K., Stratton C. J., Montak-hab M. M., Allenson S. G. In vitro sperm capacitation and transcervical intrauterine insemination for the treatment of refractory infertility: phase I. Fertil. Steril. 1984; 41: 260–4
- Rich-Edwards J. W., Goldman M. B., Willet W. C., Hunter D. J., Stampfer M. J., Colditz G. A., Manson J. E. Adolescent body mass index and infertility caused by ovulatory disorder. Am.J. Obstet. Gynecol 1994; 171: 171–7
- Remorgida V., Giordano M., Lancra P., Costan-tini S., de Cecco L. The relationship between body composition and plasma concentrations of exogenously administered urinary follicle stimulating hormone. Hum. Reprod. 1993; 8: 1001–4
- Reid R. L., Van Vugt D. A. Weight-related changes in reproductive function. Fertil. Steril. 1987; 48: 905–13
- Dale P. O., Tanbo T., Vaaler S., Abyholm T. Body weight, hyperinsulinemia, and gonadotropin levels in the polycystic ovarian syndrome: evidence of two distinct populations. Fertil. Steril 1992; 58: 487–91
- Anttila L., Ding Y. Q., Ruutiainen K., Erkkola P., Irjala K., Huhtamemi I. Clinical features and circulating gonadotropin insulin and androgen interactions in women with polycystic ovarian disease. Fertil. Steril 1991; 55: 1057–61
- Nobels F., Dewailly D. Puberty and polycystic ovarian syndrome: the insulin/insulin like growth factor I hypothesis. Fertil. Steril 1992; 58: 655–66
- Poison D. W., Reed M. J., Scanlon M. J., Quiney N., Franks S. Androstene-dione concentrations following dexamethasone suppression: correlation with clomiphene responsiveness in women with polycystic ovary syndrome. Gynecol. Endocrinol 1988; 2: 257–64
- Shoham Z., Patel A., Jacobs H. S. Polycystic ovarian syndrome: safety and effectiveness of stepwise and low-dose administration of purified follicle-stimulating hormone. Fertil. Steril 1992; 55: 1051–6